Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic Biopsy
Status:
Withdrawn
Trial end date:
2018-11-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if treatment with topotecan by an alternative
method, direct delivery into brain tumors, is safe and well tolerated. The Cleveland
Multiport Catheter is a new, investigational device that will be used to deliver topotecan
into your brain tumor. A second purpose of this study is to determine whether the Cleveland
Multiport Catheter can be used effectively and safely to deliver topotecan into your brain
tumor.
This study will also determine the best dose of topotecan to deliver to your tumor with use
of the Cleveland Multiport Catheter and will also examine how your tumor responds to
treatment with topotecan.